Position in PSNL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,320,292
New position
Shares Held
247,783
first reported quarter
Ownership
0.232%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#38
of 158 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 84%
Shared 0%
None 16%
Derivatives in PSNL
reported options exposure · as of Jun 30, 2026CallValue
$810,750
CallShares
470,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026STEMPOINT CAPITAL LP holds $4,898,792 across 2 Diagnostics & Research names. PSNL ranks #1 (67.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PSNL |
Personalis, Inc.
This page
|
247,783 | $3,320,292 | |
| 2 | BDSX |
Biodesix Inc
|
70,000 | $1,578,500 |
All Filings in PSNL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $810,750 | 470,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $3,320,292 | 247,783 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||